Stakeholders validate National Strategic Health Development Plan for cohesive implementation framework

Abuja 18 May 2017 - This week, stakeholders converged in Abuja from 15-16 May, 2017 to validate Nigeria’s draft National Strategic Health Development Plan Framework II (NSHDP II). The framework will guide government at both states and federal levels to develop specific plans that will feed into the overall Health Strategic Plan. The Minister of Health, Professor Isaac Adewole, in his address encouraged states to develop state-specific plans using NSHDP II framework as a guide to achieve coherence between local operational plans and the national strategic plan. “For the NSHDP II to be effective, it must be linked to sub-national operational plans, at the state or local government level”, Professor Adewole emphasized. The NSHDP II framework founded on the eight pillars of the health system, links health service delivery with system strengthening which include: Leadership and Governance for Health; Health Service Delivery; Human Resources for Health; Financing for Health; National Health Management Information System; Partnerships for Health; Community Participation and Ownership; and Research for Health. World Health Organization (WHO) actively supported the validation of NSHDP II framework, as part of the larger process that aims to align country priorities with the real health needs of the population so that people across the country will have access to quality health care, and live longer, healthier lives. It will also generate buy-in across different tiers of government, health and development partners, civil society and the private sector in order to optimize the utilization of available resources for health. However, Dr Wondimagegnehu Alemu the WHO country Representative to Nigeria, reminded participants at the workshop that the implementation of the NSHDP II will require ownership, oversight, resourcing and accountability. He stressed that WHO will continue to support the NHSDP II implementation process by providing appropriate technical assistance and platforms for policy dialogue as well as ensuring evidence based costing. The validation workshop was attended by the Minister of Health, the Minister of State for Health, Commissioners of Health from all 36 States, Development Partners and other stakeholders.

Major research funders and international NGOs to implement WHO standards on reporting clinical trial results

Major research funders and international NGOs to implement WHO standards on reporting clinical trial results News release 18 MAY 2017 | GENEVA - Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly. In a joint statement, the Indian Council of Medical Research, the Norwegian Research Council, the UK Medical Research Council, Médecins Sans Frontières and Epicentre (its research arm), PATH, the Coalition for Epidemic Preparedness Innovations (CEPI), Institut Pasteur, the Bill & Melinda Gates Foundation, and the Wellcome Trust agreed to develop and implement policies within the next 12 months that require all trials they fund, co-fund, sponsor or support to be registered in a publicly-available registry. They also agreed that all results would be disclosed within specified timeframes on the registry and/or by publication in a scientific journal. Today, about 50% of clinical trials go unreported, according to several studies, often because the results are negative. These unreported trial results leave an incomplete and potentially misleading picture of the risks and benefits of vaccines, drugs and medical devices, and can lead to use of suboptimal or even harmful products. "Research funders are making a strong statement that there will be no more excuses on why some clinical trials remain unreported long after they have completed," said Dr Marie-Paule Kieny, Assistant Director-General for Health Systems and Innovation at WHO. The signatories to the statement also agreed to monitor compliance with registration requirements and to endorse the development of systems to monitor results reporting. "We need timely clinical trial results to inform clinical care practices as well as make decisions about allocation of resources for future research," said Dr Soumya Swaminathan, Director-General of the Indian Council of Medical Research. "We welcome the agreement of international standards for reporting timeframes that everyone can work towards." In 2015 WHO published its position on public disclosure of results from clinical trials, which defines timeframes within which results should be reported, and calls for older unpublished trials to be reported. That position builds on the World Medical Association’s Declaration of Helsinki in 2013. Today’s agreement by some of the world’s major research funders and international NGOs will mean the ethical principles described in both statements will now be enforced in thousands of trials every year. "Requiring summary results of clinical trials to be made freely available through open access registries within 12 months of study completion is good for both science and society," said Dr Jeremy Farrar, Director of the Wellcome Trust. "Not only will this help ensure that these research findings are more discoverable, but it will also reduce reporting biases, which currently favour publication of trials which have a positive outcome. Today’s statement is in line with Wellcome’s broader ambition to make all research outputs which arise from our funding more findable, accessible, and re-usable." Most of these trials and their results will be accessible via WHO’s International Clinical Trials Registry Platform, a unique global database of clinical trials that compiles data from 17 registries around the world, including the United States of America’s clinicaltrials.gov, the European Union’s Clinical Trials Register, the Chinese and Indian Clinical Trial Registries and many others. International Clinical Trials Registry Platform "We fully support this statement and look forward to working towards increasing the availability of results from clinical trials,” said Dr John-Arne Røttingen, Chief Executive of the Research Council of Norway. “The public disclosure of results from clinical trials will improve resource

Seventieth World Health Assembly

Seventieth World Health Assembly

Gombe set to domesticate National Health Act

BY DANJUMA WILLIE, GOMBE A draft bill for the domestication of the National Health Act in Gombe State is set for presentation to the Gombe State Governor, Alhaji Ibrahim Hassan Dankwambo who is expected to forward it to the Gombe State House of Assembly. The draft bill is known as “A law to provide for the regulation, development and management of Gombe State health system and for other matters connected therewith, 2017”. The Chairman for the sub-committee for the State Technical Working Group on the National Health Act, Dr. James Mahdi, stated this to newsmen shortly after a validation meeting of the committee in Gombe. He said the committee drafted the bill out of the National Health Act of Nigeria and that it must go through the State House of Assembly before an executive assent just the same way the National Health Act went at the national level before being passed into law during the administration of Goodluck Jonathan. “The Act is needed to be domiciled in the thirty six states of Nigeria. Gombe and Lagos States are taking the lead in this domestication and what we have done in the committee is to draft a bill out of the national Act of Nigeria. It is now a Gombe State Health System Bill which must go through the processes that it went at the national level to be passed in to law”, Dr James stated. He added that, “We are now at the stage where by the draft bill has under gone so many processes, all stake holders have been sensitized about it and all inputs are been brought in in-view of peculiarities to the culture and traditions of the people of the state so that we can now have a health system that is workable within the national health act of Nigeria at Gombe state, finally as an act in Gombe state health system”. He explains further that the act is achievable because it has now defined the role and functions of all tiers of government at the primary health care as well as the state level and the federal level in view of primary, secondary and tertiary health care. It also revealed the roles of all health workers. Dr. Mahdi said, the act equally tells about linkages within the system stressing that, “a health personnel refer cases that are beyond his capacity to the next capacity and to the highest capacity as the case might be, I’m sure it is going to be workable and implemented with the support of the people of Gombe state”.

New Ebola death confirmed; 300,000 doses of vaccine ‘ready’

The GAVI global vaccine alliance said on Friday some 30

0,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak of the disease, after the World Health Organisation (WHO) confirmed a fatal case in Congo. The vaccine, known as “rVSV-ZEBOV”, was shown to be highly protective against Ebola in clinical trials published in December 2016. A spokesperson for the WHO told Reuters on Friday that a person in the Democratic Republic of Congo had died after becoming infected with Ebola, a contagious virus that causes hemorrhagic fever. The experimental vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published in 2016 The vaccine was studied in a trial involving 11 841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more after vaccination. In comparison, there were 23 cases 10 days or more after vaccination among those who did not receive the vaccine. The trial was led by WHO, together with Guinea’s Ministry of Health, Medecins sans Frontieres and the Norwegian Institute of Public Health, in collaboration with other international partners. “While these compelling results come too late for those who lost their lives during West Africa’s Ebola epidemic, they show that when the next Ebola outbreak hits, we will not be defenceless,” said Marie-Paule Kieny, WHO’s Assistant Director-General for Health Systems and Innovation, and the study’s lead author. The vaccine’s manufacturer, Merck, Sharpe & Dohme, this year received Breakthrough Therapy Designation from the United States Food and Drug Administration and PRIME status from the European Medicines Agency, enabling faster regulatory review of the vaccine once it is submitted. Since Ebola virus was first identified in 1976, sporadic outbreaks have been reported in Africa. The 2013–2016 West African Ebola outbreak, which resulted in more than 11 300 deaths, highlighted the need for a vaccine. The trial took place in the coastal region of Basse-Guinée, the area of Guinea still experiencing new Ebola cases when the trial started in 2015. The trial used an innovative design, a so-called “ring vaccination” approach, the same method used to eradicate small pox. When a new Ebola case was diagnosed, the research team traced all people who may have been in contact with that case within the previous three weeks, such as people who lived in the same household, were visited by the patient, or were in close contact with the patient, their clothes or linen, as well as certain “contacts of contacts”. A total of 117 clusters (or “rings”) were identified, each made up of an average of 80 people. (Reuters/NAN) Source http://www.premiumtimesng.com/news/headlines/231070-ebola-death-confirmed-300000-doses-of-vaccine-ready.html

Nigeria Launches National Action Plan on Women, Peace, Security

Nigeria Launches National Action Plan on Women, Peace, Security The Minister of Women Affairs and Social Development, Aisha Al-Hassan, has called for recognition in Nigeria of the pivotal role of women in conflict management, conflict resolution and sustainable peace. Mrs. Alhassan made the call on Tuesday in Abuja at the launch of the revised National Action Plan for the Implementation of the United Nation Security Council Resolution, UNSCR 1325, and Related Resolutions on Women, Peace and Security in Nigeria. The event was held at the Banquet Hall of Presidential Villa, Abuja. UNSCR 1325 was the first official and lawful global document to acknowledge the lopsided and heavier toll that war and conflict have on women and girls in Nigeria. The Federal Ministry of Women Affairs And Social Development developed the revised National Action Plan in partnership with the United Nation Security Council, UNSC. According to Mrs. Al-Hassan, in spite of women’s proven natural reconciliation and stabilizing roles in the family, they have continued to be excluded from meaningful participation in peace processes. “The UNSC had adopted Resolution 1325 13 years ago, acknowledging the underrepresentation of women in peace processes and calling on member states to take action to rectify the issues. “The resolution also acknowledged the disproportionate impact of violence on women especially in conflict contexts,” she said. Nigeria came on board in August of 2013 by launching the first National Action Plan to domesticate UNSCR 1325 with the support of the Nigeria Stability and Reconciliation Programme (NSRP) and UN Women. Eight NSRP-supported states domesticated the NAP in Nigeria. They are Bayelsa, Borno, Delta, Kaduna, Kano, Plateau, Rivers and Yobe states. “The first NAP had gaps and did not take care of emerging issues like the insurgency, violent extremism, among others, there was therefore very urgent need to have the NAP revised”, the minister said. “Insecurity and transnational border crimes, gender, responsive inclusion in peace architecture, violence against women, girls, children and communal crises are the major peace concerns of women. These, she said have been captured in the second NAP”, she added. The minister called on Nigerians to support government in actualizing gender balance into policies, programmes and organisations in Nigeria through the national gender policy. In attendance at the launching were the wives of state governors represented by wife of Bauchi State governor, Hadiza Abubakar; the Minister of Justice and Attorney-General of the Federation, Abubakar Malami; Transport Minister, Rotimi Amaechi; diplomats; traditional leaders and representative of the Kaduna State governor. The representative of the Kaduna State governor, Hafsat Baba, said women affairs are of apex importance especially in driving matters in the society. “Our women are indeed an embodiment of all virtues and this is the right time for our inclusion in leadership, conflict resolution and important decision making. “The UNSCR 1325 is one sure platform that aids this process. I join the Hon. Minister to challenge all relevant stakeholders in our nation’s women and social development matters to rally round and ensure total and smart implementation of this action plan. “At such challenging times, Nigeria is in dire need for restructuring of her social safety net and revising of our National Action Plan on UNSCR 1325 is a single most important step towards achieving that”. The governor spoke on the efforts put in place by the Kaduna State government in strengthening resolve of the UNSCR 1325. “In recognition of the importance of women inclusion in peace building processes, addressing violence against women and girls and ensuring peace and security operations, policies and programmes through integration of gender perspectives, Kaduna State launched its State Action Plan on women, peace and security (SAP Resolution 1325) in December 2016 with the support of NSRP towards achieving the programmes on wo

Heart attack risk' for common painkillers

 A fresh study suggests there may be a link between taking high doses of common anti-inflammatory painkillers - such as ibuprofen - and heart attacks. The paper, published in The BMJ, builds on a previous body of work linking these drugs to heart problems. This research suggests the risk could be greatest in the first 30 days of taking the drugs. But scientists say the findings are not clear cut. They say other factors - not just the pills - could be involved. In the study an international team of scientists analysed data from 446,763 people to try to understand when heart problems might arise. They focused on people prescribed non-steroidal anti-inflammatory drugs (such as ibuprofen, diclofenac, celecoxib and naproxen) by doctors rather than those who bought the painkillers over the counter. 'Raise awareness' Studying the data from Canada, Finland and the UK, researchers suggest taking these Nsaid painkillers to treat pain and inflammation could raise the risk of heart attacks even in the first week of use. And the risk was seen especially in the first month when people were taking high doses (for example more than 1200mg of ibuprofen a day) . But scientists say there are a number of factors that make it difficult to be absolutely certain of the link. Are the painkillers definitely to blame? Kevin McConway, emeritus professor of statistics at The Open University, said the paper threw some light on possible relationships between Nsaid painkillers and heart attacks. But he added: "Despite the large number of patients involved, some aspects do still remain pretty unclear. "It remains possible that the painkillers aren't actually the cause of the extra heart attacks." He said if, for example, someone was prescribed a high dose of a painkiller because of severe pain, and then had a heart attack in the following week, it would be "pretty hard" to tell whether the heart attack had been caused by the painkiller or by whatever was the reason for prescribing it in the first place, It could even be down to something else entirely, he said. Prof McConway also pointed out that other influences on heart health - such as smoking and obesity - could not be taken into account fully and could be partly to blame. What should patients do? Doctors are already aware from previous studies that non-steroidal anti-inflammatory drugs could increase the risk of heart problems and strokes. And current UK guidelines state that Nsaids must be used carefully in people with heart problems and in some cases (such as very severe heart failure) they should not be used at all. Dr Mike Knapton of the British Heart Foundation, suggests patients and doctors weigh up the risks and benefits of taking high doses of these common painkillers, particularly if they have survived a heart attack or are at higher risk. Meanwhile, GP leader Prof Helen Stokes-Lampard said it was important that any decision to prescribe was based on a patient's individual circumstances and medical history, and was regularly reviewed. She said that as new research was published, it was important that it was taken on board to help inform guidelines. But she added: "The use of Nsaids in general practice to treat patients with chronic pain is reducing, and some of the drugs in this study are no longer routinely prescribed in the UK, such as coxibs, as we know that long-term use can lead to serious side-effects for some patients." What about over-the-counter use? This paper looks at patients prescribed painkillers rather than people buying them in a shop or taking them without medical advice. And it suggests higher doses than those often recommended for one-off use (for example more than 1200mg of ibuprofen a day) carry some of the greatest risks. But Prof Helen Stokes-Lampard said the study should also raise awareness among patients who self-medicated with Nsaids to treat their pain. According to NHS advice, people should generally take the lowest dose of Nsaids for the shortest time possible. And if people find they need to take Nsaids very often or are taking higher doses than recommended, medical advice should be sought. How big are the risks? Independent researchers say one of the main pitfalls of the study is it does not clearly spell out what the absolute risk - or the baseline risk of people having a heart attacks - is. And they say without an understanding of the baseline, it is then hard to judge the impact of any possible increase in risk. Meanwhile, Prof Stephen Evans, of the London School of Hygiene and Tropical Medicine, said though the study indicated that even a few days' use was associated with an increased risk, it might not be as clear as the authors suggested. He added: "The two main issues are that the risks are relatively small, and for most people who are not at high risk of a heart attack, these findings have minimal implications." S:

http://www.bbc.com/news/health-39858179

Malaria cause 11% deaths in Gombe

The Director Public Health at the Gombe State Ministry of Health, Dr. Joshuah Abubakar, has said that malaria infection during pregnancy was a significant public health problem with substantial risks for the pregnant woman, her fetus and newborn child. Dr. Abubakar disclosed this while speaking during the media round table discussion organised by MamaYe E4A in Gombe to commemorate the World Malaria Day. According to him, 11 percent of maternal deaths in Gombe is caused by malaria, adding that in 2014 more than 80 percent households received treated mosquito nets in Gombe but the utilization was poor. Dr. Abubakar said in Nigeria recent studies show that 60 percent of General Out Patient (GOP) was due to malaria, 30 percent of hospital admission was due to malaria, 30 percent of under-five deaths was also due to malaria as well as 25 percent of infant deaths. Also speaking, Dr. Alfred Masa, Consultant Obstetric at the Federal Teaching Hospital Gombe, stressed the need for pregnant women to take their Sulfadoxine Pyrimethamine (SP) in the presence of caregivers in the hospital, following the observations that pregnant women do not normally take it. He said that the drugs are recommended at 16 weeks of pregnancy or when the woman starts feeling the baby kick, adding that pregnant women should always use treated mosquito nets to be protected from malaria infection. “If malaria is prevented in pregnant women, you prevent 30 percent anemia, 30 percent maternal deaths and 25 percent neonatal deaths,” he said. Narrating their ordeals, two pregnant women described their experience as terrible. Mrs. Magdalene Alex said she was diagnosed with malaria because she ignored the SP drugs, which were given to her in the hospital, and the experience was terrible. For Mrs. Samira Sabo, she explained that though she was given the drugs but she did not take it until she started experiencing abnormality. Sent from Yahoo Mail on Android

Gombe inaugurated two committee on save one million live in the state

Gombe inaugurated two committee on save one million live in the state

BY AUWAL AHMAD Gombe state Ministry of Health in collaboration with Save the Children International has inaugurated two committee on the Saving One Million lives Programme for Results (SOML-P for R) in the state with aim of improving the lives of mothers and children. The state Commissioner of Health Dr. Kennedy Ishaya while speaking during the inauguration ceremony in Gombe on Tuesday, said that the two committee are state steering committee on operationalization of National Health Act and Saving one million lives programme for result. According to the Commissioner “The Programme would bring change in the way health business done by focusing on result and governance”. He said that the programme being funded from a N140 billion ($500 million) World Bank credit, was negotiated by the Federal Government from which $1.5million had been disbursed to states and the Federal Capital Territory (FCT) to drive the delivery of the programme and enable states address legacy issues Our Correspondent reported that programme expected to deliver high impact, evidence-based and cost effective health interventions based on six ‘pillars’, namely: Maternal, newborn and child health, childhood essential medicines and increase treatment of important childhood diseases, improve child nutrition, immunisation malaria control and the elimination of mother to child transmission (EMTCT) of HIV. And initiative was not new, but that it would give a new lease of life to the National Strategic Health Development Plan (NSHDP) and State Strategic Health Development Plans (SHDPs) through innovative financing mechanism. The field Manager Save the Children Ms. Altine Lewi urged stakeholders to imbibe the culture of performance-based programming so that results could be achieved within a short time.

World Malaria Day 2017: MamaYe journalists for MNH Accountability draw attention to Malaria in Pregnancy

World Malaria Day 2017: MamaYe journalists for MNH Accountability draw attention to Malaria in Pregnancy To commemorate the 2017 World Malaria Day, the sub-committees responsible for Knowledge Management and Communication (KMC) in the State Accountability Mechanism for Maternal and Newborn Health in Gombe (Gombe State Accountability Mechanism for Maternal and Newborn Health – GoSAM) and Bauchi (Bauchi State Accountability Mechanism for Maternal and Newborn Health – BASAM) states, are to draw attention to the problem of malaria in pregnancy in the two states and the entire Nigerian nation. The activities planned around the 2017 World Malaria Day include a media roundtable and radio and television programmes aimed at public enlightenment and public policy implementation to address the problem of malaria in pregnancy which, according to the World Health Organisation, has consequences for not just the pregnant woman, but the unborn baby as well (see also this Lancet article). The Bauchi group, BaSAM KMC, took the decision at its 2017 second quarterly review meeting held 7 April, where activities in the first quarter were reviewed and plans for the second quarter were discussed. The Gombe group followed with their own plan, and both will hold the media roundtable simultaneously on 26 April. Although malaria is still a global health problem with 212 million new cases in 2015, out of which there were 429,000 deaths, including one child dying from malaria every 2 minutes, the mood around the 2017 World Malaria Day is celebratory. This is because of prevention and treatment successes recorded between 2010 and 2015. During the period, there was a 21 per cent decrease in the global malaria incidence, and a 29 per cent decline in mortality, WHO said in a statement. “In sub-Saharan Africa, 663 million cases of malaria were prevented between 2010 and 2015 through the scale-up of core malaria control tools,” it added, explaining that insecticide-treated nets have had the greatest impact, “accounting for an estimated 69 per cent of all cases prevented through control tools.” In areas with high malaria transmission, young children and pregnant women are particularly vulnerable to malaria infection and death. In 2015, 70 per cent (more than two-thirds) of all malaria deaths occurred among under-5 children. To protect pregnant women from malaria, WHO recommends Intermittent Preventive Treatment in Pregnancy (IPTp), which prevents maternal and infant mortality, anaemia, and other adverse effects of malaria during pregnancy. Administration of IPTp on pregnant women is recommended at routine antenatal care visits in areas of stable malaria transmission in sub-Saharan Africa. However, IPTp coverage remains low. In 2015, it was just 31 per cent. In other words, an estimated 69 per cent of pregnant women still do not access the WHO-recommended three or more doses of IPTp. On 2017 World Malaria Day, WHO will call on all malaria-affected countries and their development partners to close the gap in coverage of IPTp.

World Malaria Day

Yesterday was World Malaria Day (WMD). The World Health Organisation (WHO) declared that, despite the substantial gains in malaria responses, the disease has remained a major public health threat to people. The WHO at an event in Nairobi Kenya, said the global tally of malaria reached 429,000 deaths and 212 million new cases in 2015, with one child dying from malaria every two minutes. WHO in a report released yesterday titled “Malaria prevention works: Let’s close the gap” showed critical gaps in prevention coverage, particularly in sub-Saharan Africa. According to the WHO, more than 663 million cases have been averted in sub-Saharan Africa since 2001. The Director-General of WHO, Dr. Margaret Chan, called for accelerated scale-up of efforts to prevent malaria and save lives. She said: “whom recommended tools have made a measurable difference in the global malaria fight. But we need a much bigger push for prevention, especially in Africa, which bears the greatest burden of malaria.” In view of this, Gombe state Malaria Control Office distributed anti-malaria drugs free of charge to the students of the State University The State Malaria Control Manager, Malam Muhammad Babagana, disclosed this while speaking to Journalists in Gombe. According to him, the students were screened and those found with malaria parasites were given anti-malaria drugs. Babagana said that, the office had also distributed 150 Long Lasting Insecticide Nets (LLINs) to the students. He said that, the state government was creating awareness on effects of malaria and how students could protect themselves. Babagana said the state government had also inspected the sanitary condition of students’ hostels and had applied some chemicals. He said the state government is giving the office some drugs to treat those that were infected. According to him, anti-malaria drugs are given to pregnant women at ante-natal clinics to prevent malaria. “But the support is not like the years back when we had the full support of the World Bank for Malaria Control Booster Project. “We are appealing to government to do more because we do not have many activities in the office now, and we want to sustain what the World Bank left.

Gombe to begin CSM vaccination soon-Commissioner

Gombe to begin CSM vaccination soon-Commissioner AUWAL AHMAD In effort to prevents the Cerebral Spinal Meningitis outbreak,the Gombe state Ministry of Health said to have perfected a plan to begin vaccination of children One to 6 years on CSM before the rainy season in the state. The state commissioner of health, Dr Kennedy Ishaya disclosed this in an interview with the Journalists in Gombe on Friday shortly after meeting with the state committee on Epidemic Rapid Response on health issues. He said, they would focus on that particular group because they are the most vulnerable whenever there is outbreak of such health issue. Dr. Ishaya said that the rainy season is fast approaching,saying that CSM is associated with winds. “Although we have not recorded any CSM case in Gombe state but we want to take precautions, to curtail the problem in case it happens He added that they have been receiving unconfirmed cases of CSM sporadically but they were treated even before their sample was taken for test, and Gombe people travel daily to the North West where cases of CSM were reported. “There are the likelihood of importing the case to Gombe hence the needs to take measures,” he said. “We want to make arrangements of adequate drugs ahead of time, we do not want fire brigade approach,” he said. The commissioner also said, the state is looking for a possibility of establishing lab in Gombe, instead of taking samples to Lagos. He said, the meeting focused on four health issues that are of threats to human lives, namely CSM, Miseales, Lassa fever and Polio. Ishaya, further advocates for non-killing of cats in Gombe because is a natural predator of rats. “Stop killing cats, they are natural predator of rats, and we are all aware that rats cause Lassa fever,” he said. He said, the state government has secured about 200 ampoules of Lassa fever drugs in case of outbreak.

Gombe MNCH APPEAL TO STATE ASSEMBLY

Gombe The Maternal and New-born Child Health (MNCH) Coalition has appealed to the State House of Assembly to establish a law that will required contractors to remit one per cent of their contract sums for nutrition activities, in effort to curbing acute malnutrition in the state. The Vice Chairman of the coalition, Malam Sani Adamu Jauro made the appeal in an interview with Journalists in Gombe shortly after the coalition’s quarterly meeting on Thursday. “If the law is established and one percent of any contract awarded to any contractor in the state can be remitted for nutrition activities, it would go a long way in complementing government’s efforts in tackling the issue of malnutrition in the state”, the Vice Chairman of the Coalition said. Malam Sani Jauro said, the Coalition would also pay advocacy visits to corporate organisations to ask them to contribute as part of their corporate social responsibility as well as philanthropists that may be willing to support this cause. The Vice Chairman expressed happiness over the approval by the State Government of the coasted operational plan for nutrition for the period of 2016 to 2021 amounting to N3.5 billion as presented by the Coalition with the aim of tackling the issue of malnutrition in the state. He stated that it was also commendable that the Gombe State Government has allocated N120 million Naira for the year 2017 budget on nutrition activities as against N50 million in the year 2016. The aim of the Coalition is to advocate the improvement and safe guarding of the health of maternal and new-born children from stakeholders including the media and Civil Society Organisations in the state.